It is also worth noting that while semaglutide has not been linked to an increased risk of cancer, people with type 2 diabetes have an increased risk of developing certain types of cancer, such as liver and pancreatic cancer
The trial in people with T2D included 281 participants (mean age 56 years, 56% women, mean BMI 35.0 kg/m 2 , mean HbA1c 8.3%) treated with lifestyle only and/or metformin, with similar intervention arms to the obesity trial, albeit retatrutide 0.5 mg rather than 1 mg, and dulaglutide 1.5 mg was an additional comparator [46]
These guidelines recommend a combination of aerobic activities, such as walking, cycling, or swimming, with resistance training
Regular sessions and maintenance protocols are key to achieving and sustaining results
Lancet 380 , 16061619 (2012)